RLMD
insider transactionsRELMADA THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 4 different insiders made open-market purchases in the last 365 days, totalling $2.5M.
Net shares · 365d
+1.3M
1.3M buy · 0 sell
Net value · 365d
$2.5M
$2.5M in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
9
1.3M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Shenouda Maged KEY
Chief Financial Officer
$48.1K
11.7K sh · $4.12
Own +1%
-
Buy·P
TRAVERSA SERGIO KEY
Chief Executive Officer
$113.3K
27.5K sh · $4.12
Own +2%
-
Grant·A
CA and CO
$0
828.0K sh
Own New
-
Grant·A
Director
$0
164.0K sh
Own New
-
Grant·A
Director
$0
164.0K sh
Own New
-
Grant·A
$0
828.0K sh
Own New
-
Grant·A
Shenouda Maged KEY
Chief Financial Officer
$0
828.0K sh
Own New
-
Grant·A
TRAVERSA SERGIO KEY
Chief Executive Officer
$0
1.2M sh
Own New
-
Grant·A
Director
$0
164.0K sh
Own New
-
Buy·P
TRAVERSA SERGIO KEY
Chief Executive Officer
$599.5K
272.5K sh · $2.20
Own +27%
-
Buy·P
CAO and COO
$299.2K
136.0K sh · $2.20
Own +51%
-
Buy·P
Shenouda Maged KEY
Chief Financial Officer
$1.1M
500.0K sh · $2.20
Own +173%
-
Buy·P
Chief Operating Officer
$198.0K
90.0K sh · $2.20
Own +22%
-
Buy·P
TRAVERSA SERGIO KEY
Chief Executive Officer
$41.4K
56.0K sh · $0.74
Own +6%
-
Buy·P
TRAVERSA SERGIO KEY
Chief Executive Officer
$86.7K
129.5K sh · $0.67
Own +16%
-
Buy·P
TRAVERSA SERGIO KEY
Chief Executive Officer
$49.9K
80.5K sh · $0.62
Own +11%
-
Grant·A
Chief Operating Officer
$0
400.0K sh
Own New
-
Grant·A
Director
$0
100.0K sh
Own New
-
Grant·A
CA and CO
$0
400.0K sh
Own New
-
Grant·A
Shenouda Maged KEY
Chief Financial Officer
$0
600.0K sh
Own New
-
Grant·A
TRAVERSA SERGIO KEY
Chief Executive Officer
$0
800.0K sh
Own New
-
Grant·A
Director
$0
100.0K sh
Own New
-
Grant·A
Director
$0
100.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 15, 2025 | Shenouda Maged KEY | Buy P | 11.7K | $48.1K |
| Dec 15, 2025 | TRAVERSA SERGIO KEY | Buy P | 27.5K | $113.3K |
| Dec 12, 2025 | Ence Chuck | Grant A | 828.0K | $0 |
| Dec 12, 2025 | CASAMENTO CHARLES J | Grant A | 164.0K | $0 |
| Dec 12, 2025 | GLASSPOOL JOHN | Grant A | 164.0K | $0 |
| Dec 12, 2025 | Kelly Paul Edward | Grant A | 828.0K | $0 |
| Dec 12, 2025 | Shenouda Maged KEY | Grant A | 828.0K | $0 |
| Dec 12, 2025 | TRAVERSA SERGIO KEY | Grant A | 1.2M | $0 |
| Dec 12, 2025 | Fedeli Fabiana | Grant A | 164.0K | $0 |
| Nov 5, 2025 | TRAVERSA SERGIO KEY | Buy P | 272.5K | $599.5K |
| Nov 5, 2025 | Ence Chuck | Buy P | 136.0K | $299.2K |
| Nov 5, 2025 | Shenouda Maged KEY | Buy P | 500.0K | $1.1M |
| Nov 5, 2025 | Kelly Paul Edward | Buy P | 90.0K | $198.0K |
| Aug 28, 2025 | TRAVERSA SERGIO KEY | Buy P | 56.0K | $41.4K |
| Aug 27, 2025 | TRAVERSA SERGIO KEY | Buy P | 129.5K | $86.7K |
| Aug 26, 2025 | TRAVERSA SERGIO KEY | Buy P | 80.5K | $49.9K |
| Jun 26, 2025 | Kelly Paul Edward | Grant A | 400.0K | $0 |
| Jun 26, 2025 | CASAMENTO CHARLES J | Grant A | 100.0K | $0 |
| Jun 26, 2025 | Ence Chuck | Grant A | 400.0K | $0 |
| Jun 26, 2025 | Shenouda Maged KEY | Grant A | 600.0K | $0 |
| Jun 26, 2025 | TRAVERSA SERGIO KEY | Grant A | 800.0K | $0 |
| Jun 26, 2025 | GLASSPOOL JOHN | Grant A | 100.0K | $0 |
| Jun 26, 2025 | Fedeli Fabiana | Grant A | 100.0K | $0 |
About RLMD insider trading
This page tracks insider transactions for RELMADA THERAPEUTICS, INC. (RLMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.